Mannatech, Incorporated
(NASDAQ: MTEX), a global health and
wellness company committed to transforming lives to make a better
world, today announced financial results for its third quarter of
2022.
Third Quarter End
Results
Third quarter net sales for 2022 were $35.5 million, a decrease
of $3.9 million, or 10.0%, as compared to $39.4 million in the
third quarter of 2021. Our net sales declined 1.3% on a constant
dollar basis (see Non-GAAP Measures, below) as foreign exchange
decreased GAAP net sales by $3.4 million, mostly due to the decline
of the Korean Won and Japanese Yen.
Third quarter operating income for 2022 was $1.4 million as
compared to $3.3 million for the third quarter of 2021.
Net income was $1.2 million, or $0.61 per diluted share, for the
third quarter of 2022, as compared to net income of $2.9 million,
or $1.44 per diluted share, for the third quarter of 2021.
For the three months ended September 30, 2022, overall selling
and administrative expenses decreased by $0.5 million to $6.7
million, as compared to $7.2 million for the same period in 2021.
The decrease in selling and administrative expenses consisted of a
$0.7 million decrease in payroll costs, and a $0.1 million decrease
in warehouse costs, which was partially offset by a $0.3 million
increase in marketing costs.
For the three months ended September 30, 2022, other operating
costs increased by $0.1 million to $5.1 million, as compared to
$5.0 million for the same period in 2021. The increase in operating
costs was primarily due to a $0.1 million increase in travel and
entertainment.
The approximate number of new and continuing independent
associate and preferred customer positions held by individuals in
Mannatech’s network and associated with purchases of products as of
September 30, 2022 and 2021 were approximately 150,000 and 166,000,
respectively. Recruitment of new independent associates and
preferred customers decreased by 23.0% to 19,273 in the third
quarter of 2022 as compared to 25,036 in the third quarter of
2021.
Year-to-date Third Quarter
Results
For the nine months ended September 30, 2022, net sales were
$102.9 million, a decrease of $17.4 million, or 14.5%, as compared
to $120.3 million for the same period in 2021. Our net sales
declined 8.2% on a constant dollar basis (see Non-GAAP Measures,
below) as foreign exchange decreased GAAP net sales by $7.5 million
mostly due to the decline of the Korean Won and Japanese Yen.
Income from operations decreased to $2.2 million for the nine
months ended September 30, 2022, from $8.1 million in the same
period in 2021.
Net income was $2.0 million, or $1.01 per diluted share, for the
nine months ended September 30, 2022, as compared to net income of
$7.3 million, or $3.47 per diluted share, for the same period in
2021.
Non-GAAP Measures
In addition to results presented in accordance with GAAP, this
press release and related tables include certain non-GAAP financial
measures, including a presentation of constant dollar measures. We
disclose operating results that have been adjusted to exclude the
impact of changes due to the translation of foreign currencies into
U.S. dollars, including changes in: Net Sales, Gross Profit, and
Income from Operations. We believe that these non-GAAP financial
measures provide useful information to investors because they are
an indicator of the strength and performance of ongoing business
operations. The constant currency figures are financial measures
used by management to provide investors an additional perspective
on trends. Although we believe the non-GAAP financial measures
enhance investors’ understanding of our business and performance,
these non-GAAP financial measures should not be considered an
exclusive alternative to accompanying GAAP financial measures.
Please see the accompanying table entitled "Non-GAAP Financial
Measures" for a reconciliation of these non-GAAP financial
measures.
Safe Harbor statement
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
Section 21E of the Securities Exchange Act of 1934, as amended, and
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of
phrases or terminology such as “may,” “will,” “should,” “hope,”
“could,” “would,” “expects,” “plans,” “intends,” “anticipates,”
“believes,” “estimates,” “approximates,” “predicts,” “projects,”
“potential,” and “continues” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s
objectives, strategies, plans, goals or targets contained herein
are also considered forward-looking statements. Mannatech believes
this release should be read in conjunction with all of its filings
with the United States Securities and Exchange Commission and
cautions its readers that these forward-looking statements are
subject to certain events, risks, uncertainties, and other factors.
Some of these factors include, among others, the impact of COVID-19
on Mannatech’s business, the availability and effectiveness of
vaccines on a widespread basis, the impact of any mutations of the
COVID-19 virus, the current conflict between Russia and Ukraine,
which could adversely affect our business in certain regions, the
impact of inflation, disruptions in the supply chain, Mannatech's
inability to attract and retain associates and preferred customers,
increases in competition, litigation, regulatory changes, and its
planned growth into new international markets. Although Mannatech
believes that the expectations, statements, and assumptions
reflected in these forward-looking statements are reasonable, it
cautions readers to always consider all of the risk factors and any
other cautionary statements carefully in evaluating each
forward-looking statement in this release, as well as those set
forth in its latest Annual Report on Form 10-K, and other filings
filed with the United States Securities and Exchange Commission,
including its current reports on Form 8-K. All of the
forward-looking statements contained herein speak only as of the
date of this release.
Individuals interested in Mannatech's products or in exploring
its business opportunity can learn more at Mannatech.com
MANNATECH, INCORPORATED AND
SUBSIDIARIES
CONSOLIDATED BALANCE
SHEETS
(in thousands, except share
information)
ASSETS
September 30, 2022
(unaudited)
December 31, 2021
Cash and cash equivalents
$
15,092
$
24,185
Restricted cash
944
944
Accounts receivable, net of allowance of
$899 and $987 in 2022 and 2021, respectively
270
90
Income tax receivable
368
342
Inventories, net
15,251
12,020
Prepaid expenses and other current
assets
1,943
2,888
Deferred commissions
2,574
2,369
Total current assets
36,442
42,838
Property and equipment, net
3,613
2,882
Construction in progress
283
1,357
Long-term restricted cash
435
503
Other assets
8,757
9,220
Deferred tax assets, net
2,970
2,825
Total assets
$
52,500
$
59,625
LIABILITIES AND SHAREHOLDERS’
EQUITY
Current portion of finance leases
$
65
$
68
Accounts payable
4,581
3,969
Accrued expenses
7,504
9,224
Commissions and incentives payable
8,402
9,611
Taxes payable
1,908
2,154
Current notes payable
323
205
Deferred revenue
5,952
4,867
Total current liabilities
28,735
30,098
Finance leases, excluding current
portion
102
66
Deferred tax liabilities
—
—
Long-term notes payable
—
—
Other long-term liabilities
5,052
5,049
Total liabilities
33,889
35,213
Commitments and contingencies
Shareholders’ equity:
Preferred stock, $0.01 par value,
1,000,000 shares authorized, no shares issued or outstanding
—
—
Common stock, $0.0001 par value,
99,000,000 shares authorized, 2,742,857 shares issued and 1,874,930
shares outstanding as of September 30, 2022 and 2,742,857 shares
issued and 1,940,687 shares outstanding as of December 31, 2021
—
—
Additional paid-in capital
33,418
33,277
Retained earnings
8,567
7,708
Accumulated other comprehensive (loss)
income
(3,053
)
2,342
Treasury stock, at average cost, 867,927
shares as of September 30, 2022 and 802,170 shares as of December
31, 2021
(20,321
)
(18,915
)
Total shareholders’ equity
18,611
24,412
Total liabilities and shareholders’
equity
$
52,500
$
59,625
MANNATECH, INCORPORATED AND
SUBSIDIARIES
CONSOLIDATED STATEMENTS OF
OPERATIONS
(in thousands, except per share
information)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022
2021
2022
2021
Net sales
$
35,513
$
39,446
$
102,873
$
120,269
Cost of sales
7,416
7,903
22,427
25,251
Gross profit
28,097
31,543
80,446
95,018
Operating expenses:
Commissions and incentives
14,242
15,731
41,487
48,227
Selling and administrative expenses
6,656
7,156
20,479
21,838
Depreciation and amortization expense
716
408
1,349
1,360
Other operating costs
5,126
4,962
14,886
15,500
Total operating expenses
26,740
28,257
78,201
86,925
Income from operations
1,357
3,286
2,245
8,093
Interest income, net
19
15
57
44
Other income (expense), net
287
(19
)
288
(149
)
Income before income taxes
1,663
3,282
2,590
7,988
Income tax (provision)
(472
)
(352
)
(571
)
(735
)
Net income
$
1,191
$
2,930
$
2,019
$
7,253
Earnings per common share:
Basic
$
0.62
$
1.54
$
1.05
$
3.63
Diluted
$
0.61
$
1.44
$
1.01
$
3.47
Weighted-average common shares
outstanding:
Basic
1,906
1,903
1,932
2,010
Diluted
1,949
2,031
2,017
2,095
Non-GAAP Financial Measures (Sales, Gross Profit and Income
from Operations in Constant Dollars)
To supplement our financial results presented in accordance with
generally accepted accounting principles in the United States
(“GAAP”), we disclose operating results that have been adjusted to
exclude the impact of changes due to the translation of foreign
currencies into U.S. dollars, including changes in: Net Sales,
Gross Profit, and Income from Operations. We refer to these
adjusted financial measures as constant dollar items, which are
non-GAAP financial measures. We believe these measures provide
investors an additional perspective on trends. To exclude the
impact of changes due to the translation of foreign currencies into
U.S. dollars, we calculate current year results and prior year
results at a constant exchange rate, which is the prior year’s
rate. Currency impact is determined as the difference between
actual growth rates and constant currency growth rates.
The table below reconciles third quarter 2022 and year-to-date
constant dollar net sales, gross profit and income from operations
to our GAAP net sales, gross profit and income from operations.
Three-month period ended (in
millions, except percentages)
September 30, 2022
September 30, 2021
Constant $ Change
GAAP Measure:
Total $
Non-GAAP Measure:
Constant $
GAAP Measure:
Total $
Dollar
Percent
Net sales
$
35.5
$
38.9
$
39.4
$
(0.5
)
(1.3
)%
Product
33.6
36.8
36.9
(0.1
)
(0.3
)%
Pack sales and associate fees
1.7
1.9
2.4
(0.5
)
(20.8
)%
Other
0.2
0.2
0.1
0.1
100.0
%
Gross profit
28.1
30.9
31.5
(0.6
)
(1.9
)%
Income from operations
1.4
2.2
3.3
(1.1
)
(33.3
)%
Nine-month period ended (in
millions, except percentages)
September 30, 2022
September 30, 2021
Constant $ Change
GAAP Measure:
Total $
Non-GAAP Measure:
Constant $
GAAP Measure:
Total $
Dollar
Percent
Net sales
$
102.9
$
110.4
$
120.3
$
(9.9
)
(8.2
)%
Product
97.5
104.5
113.2
(8.7
)
(7.7
)%
Pack sales and associate fees
4.8
5.3
6.5
(1.2
)
(18.5
)%
Other
0.6
0.7
0.6
0.1
16.7
%
Gross profit
80.4
86.7
95.0
(8.3
)
(8.7
)%
Income from operations
2.2
4.1
8.1
(4.0
)
(49.4
)%
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221108005282/en/
Donna Giordano Manager, Executive Office Administration
972-471-6512 ir@mannatech.com www.mannatech.com
Mannatech (NASDAQ:MTEX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Mannatech (NASDAQ:MTEX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024